Multidisciplinary team with experience in the clinical and molecular study of rare diseases, particularly family lipodystrophies and neurogenetic syndromes
📢 New publication from our group in Aging!
A systematic review and individual-patient data analysis of survival and causes of death in classical laminopathic progeroid syndromes.
#Progeria#RareDiseases#Laminopathies#AgingResearch#AgingJrnl
https://t.co/GJvHirTY18
🙋🏾♂️Diagnostic challenge from our colleagues at @uetemlab: A sedentary woman with ↗️triglycerides, hair loss, striking muscle hypertrophy, and fat loss in limbs (but fat accumulation in face/neck)
Could this Herculean phenotype be more than it seems? 👀
https://t.co/llZhWVPtY9
📢 Nuevo artículo: Síndromes lipodistróficos y control de la diabetes.
Exploramos cómo la falta de tejido adiposo altera el manejo metabólico y su impacto clínico 👉 https://t.co/1yV5ThZbpf
#Diabetes#Lipodistrofia#Endocrinología@SEDiabetes@AELIP_
🧬Seipin (BSCL2) deficiency drives early #MASLD/#MASH and fibrosis in lipodystrophy 🐁 models, with up to ~20-fold FGF21 upregulation.
These findings point to FGF21 pathway as a promising therapeutic target.
Congrats, happy to @uetemlab team!
@IJMS_MDPI
https://t.co/AX70kqXVYw
After a lot of work, here is our new article. We are so happy! 🥳
Metabolic-associated steatotic liver disease and FGF21 dysregulation in seipin-deficient and BSCL2-associated Celia’s encephalopathy murine models https://t.co/YWg9z6dr2B #mdpiijms@IJMS_MDPI